Methods of Generating Nanoarrays and Microarrays
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 2 of these applications claim priority to application PCT/US2019/025909, filed Apr 4, 2019. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,203,612 | Methods of Generating Nanoarrays and Microarrays In force · Medium confidence | Nautilus Biotechnology, Inc. | In force | Medium confidence | ||
| US 11,603,383 | Methods of Generating Nanoarrays and Microarrays In force · Medium confidence | Nautilus Biotechnology, Inc. | In force | Medium confidence | ||
| Application 17/496,742 | Methods of Generating Nanoarrays and Microarrays Pending Not granted | Nautilus Subsidiary, Inc. | Pending | Not granted | ||
| Application 18/181,397 | Methods of Generating Nanoarrays and Microarrays Abandoned Abandoned Jul 26, 2025 | Nautilus Subsidiary, Inc. | Abandoned | Abandoned Jul 26, 2025 | ||
| Application 18/318,404 | Methods of Generating Nanoarrays and Microarrays Abandoned Abandoned Sep 30, 2025 | Nautilus Subsidiary, Inc. | Abandoned | Abandoned Sep 30, 2025 |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Nautilus, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.